Catalyst Wire Dossier Catalyst Wire Dossier

CAR-T cell therapy targeting acute myeloid leukemia (AML) - multiple candidates

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CAR-T cell therapy targeting acute myeloid leukemia (AML) - multiple candidates, covering 2026-04-24 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Multiple CAR-T Cell Therapy Targeting AML [Phase 1, Phase 2]

See pricing